Copaxone and Cannot sleep for Men aged 40-49 (a phase IV clinical study of FDA data)

Summary:

Cannot sleep is found for men aged 40-49 who take Copaxone (glatiramer acetate). This study is created by eHealthMe based on reports of 1,392 men aged 40-49 from the FDA, and is updated regularly. The information that eHealthMe analyzes includes:

Time on Copaxone when people have Cannot sleep
Top conditions
Top co-used drugs
Top other side effects

On Jul, 28, 2026

1,392 men aged 40-49 reported to have side effects when taking Copaxone.
Among them, 32 people (2.3%) have Cannot sleep

What is Copaxone?

Copaxone has active ingredients of glatiramer acetate. It is often used in multiple sclerosis. eHealthMe is studying from 56,931 Copaxone users. Check the latest studies of Copaxone.

What is Cannot sleep?

Cannot sleep is found to be associated with 4,393 drugs and 5,382 conditions by eHealthMe. Check the latest studies of Cannot sleep.

Number of reports submitted per year:

Could Copaxone cause Cannot sleep in men aged 40-49?

Time on Copaxone when people have Cannot sleep *

Severity of Cannot sleep

n/a

How people recovered from Cannot sleep

n/a

Top conditions involved for these people *:

You may use this to check any potential undetected conditions.

Gait Disturbance: 13 people, 40.62%
Muscle Spasms (muscle contraction): 3 people, 9.38%
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder): 2 people, 6.25%
Sleep Disorder: 1 person, 3.12%
Pain: 1 person, 3.12%
Lymphoedema (localized fluid retention and tissue swelling): 1 person, 3.12%
Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 1 person, 3.12%
Drowsiness: 1 person, 3.12%
Diabetes: 1 person, 3.12%

Top co-used drugs for these people *:

You may use this to check any potential interacting drugs.

Top other side effects for these people *:

You may use this to check any potential undetected side effects.

Fatigue (feeling of tiredness): 8 people, 25.00%
Weakness: 6 people, 18.75%
Dizziness: 5 people, 15.62%
Stress And Anxiety: 5 people, 15.62%
Fall: 5 people, 15.62%
Visual Impairment: 4 people, 12.50%
Confusional State: 4 people, 12.50%
Mobility Decreased (ability to move is reduced): 4 people, 12.50%
Depression: 4 people, 12.50%
Diarrhea: 4 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Copaxone and have Cannot sleep?

- Check whether Cannot sleep is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related publications that referenced our studies:

Michaud CJ, Bockheim HM, Nabeel M, Daum TE, "Diagnosis of Exclusion: A Case Report of Probable Glatiramer Acetate-Induced Eosinophilic Myocarditis", Case reports in neurological medicine, 2014 Jul .
Michaud CJ, Bockheim HM, Nabeel M, Daum TE, "Diagnosis of Exclusion: A Case Report of Probable Glatiramer Acetate-Induced Eosinophilic Myocarditis", Case reports in neurological medicine, 2014 Jul .

Related studies:

Copaxone and Cannot sleep

How the study uses the data?

The study is based on (applicable) gender, age, glatiramer acetate (the active ingredients of Copaxone) and Copaxone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.